AI CAPITAL INTELLIGENCE

科辉智药 · Series A · Approximately CNY 100,000,000 · 2026-06-25

Financing facts, at a glance

科辉智药: financing disclosed on 2026-06-25, Series A, Approximately CNY 100,000,000. Named investors: 松禾资本, 君熠投资. This is the amount disclosed for the financing, not a company valuation or an individual investor commitment.

Original source 1 · Original source 2

科辉智药 is recorded in the Industry AI / Drug discovery & life sciences segment. The disclosed financing is Series A, with an amount of Approximately CNY 100,000,000. Named investors include 松禾资本, 君熠投资.

Disclosed company name
科辉智药(Artivila Biopharma)
Disclosure date
2026-06-25
Round
Series A
Financing amount
Approximately CNY 100,000,000
Market coverage
Outside China
Sector
Industry AI / Drug discovery & life sciences
Product form
Enterprise software

Disclosed investors

松禾资本, 君熠投资

Original sources

  1. Source 1 · mp.weixin.qq.com
  2. Source 2 · artivila.com

Record reviewed as of . Reported ranges and lower bounds are retained. Financing proceeds are not company valuation.

Company funding history

Explore this sector

松禾资本 (Chinese)

君熠投资 (Chinese)

All funding records